Ramipril Dose Mix-Up Sparks UK Medicine Recall

Patients in the UK are being advised to check their blood pressure medication after a recall was issued for a batch of Ramipril capsules due to a packaging error.

Crescent Pharma Limited has recalled one batch of Ramipril 2.5mg capsules, identified as batch GR155023, after discovering that some packs may contain blister strips of the stronger 10mg dose.

The issue came to light after two strips of Ramipril 10mg capsules were found inside a sealed carton labelled as 2.5mg. As a precaution, the batch has been withdrawn from circulation.

The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed pharmacies and healthcare providers to stop distributing the affected stock and return any remaining packs to suppliers.

Ramipril is commonly prescribed to treat high blood pressure, heart failure and kidney disease.

Patients who have the recalled batch are urged to inspect both the outer packaging and the blister strips to ensure the dosage matches. Anyone who finds 10mg blister packs inside a carton labelled 2.5mg should avoid taking the medication and contact their pharmacy for guidance.

Dr Alison Cave, the MHRA’s Chief Safety Officer, warned that taking a higher dose by mistake could lead to side effects such as dizziness, fainting, tiredness and possible kidney-related complications, with vulnerable patients potentially facing greater risks.

People who believe they may have taken the incorrect dose and are experiencing symptoms are advised to seek medical advice so healthcare professionals can assess whether further checks or treatment are needed.